Title:
PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER, CONTAINING THIORIDAZINE AND PERHEXILINE AS ACTIVE INGREDIENTS
Document Type and Number:
WIPO Patent Application WO/2022/158739
Kind Code:
A1
Abstract:
The present invention relates to a pharmaceutical composition for preventing or treating cancer, containing thioridazine and perhexiline as active ingredients, and, more specifically, to a pharmaceutical composition for preventing or treating cancer, the composition being capable of exhibiting synergistic anti-cancer activity by means of the combined use of thioridazine and perhexiline.
More Like This:
WO/1993/016732 | FORMULATIONS CONTAINING HYALURONIC ACID |
WO/2000/066112 | CXCR-4 RECEPTOR ANTAGONISTS - THROMBOPOIETIN MIMETICS |
JP2022544846 | SOLVENT DELIVERY SYSTEM FOR TOPICAL DELIVERY OF ACTIVE AGENTS |
Inventors:
LEE JAE SUN (KR)
Application Number:
PCT/KR2021/019944
Publication Date:
July 28, 2022
Filing Date:
December 27, 2021
Export Citation:
Assignee:
NEW CANCER CURE BIO CO LTD (KR)
International Classes:
A61K31/5415; A61K31/4458; A61P35/00
Foreign References:
JP2003523936A | 2003-08-12 | |||
KR20030048460A | 2003-06-19 | |||
US20190070191A1 | 2019-03-07 | |||
US20150038450A1 | 2015-02-05 | |||
CN105879031A | 2016-08-24 |
Attorney, Agent or Firm:
PADO IP LAW PLLC (KR)
Download PDF:
Previous Patent: MASK AND MANUFACTURING METHOD THEREOF
Next Patent: ELECTRONIC DEVICE THAT CARRIES OUT COMMUNICATION AND OPERATION METHOD THEREFOR
Next Patent: ELECTRONIC DEVICE THAT CARRIES OUT COMMUNICATION AND OPERATION METHOD THEREFOR